The early change of SOFA score as a prognostic marker of 28-day sepsis mortality: analysis through a derivation and a validation cohort

被引:86
作者
Karakike, Eleni [1 ]
Kyriazopoulou, Evdoxia [1 ]
Tsangaris, Iraklis [2 ]
Routsi, Christina [3 ]
Vincent, Jean-Louis [4 ]
Giamarellos-Bourboulis, Evangelos J. [1 ]
机构
[1] Natl & Kapodistrian Univ Athens, Attikon Univ Hosp, Dept Internal Med 4, 1 Rimini St, Athens 12462, Greece
[2] Natl & Kapodistrian Univ Athens, Dept Crit Care Med 2, Athens 12462, Greece
[3] Natl & Kapodistrian Univ Athens, Dept Crit Care Med 1, Athens 10676, Greece
[4] Univ Libre Bruxelles, Erasme Hosp, Dept Intens Care, B-1070 Brussels, Belgium
基金
欧盟地平线“2020”;
关键词
Sequential Organ Failure Assessment (SOFA); Delta change; Sepsis; Mortality; Trial endpoints; ORGAN DYSFUNCTION; SEPTIC SHOCK; GUIDELINES;
D O I
10.1186/s13054-019-2665-5
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background Since the Sepsis-3 criteria, change in Sequential Organ Failure Assessment (SOFA) score has become a key component of sepsis identification. Thus, it could be argued that reversal of this change (Delta(SOFA)) may reflect sepsis response and could be used as measure of efficacy in interventional trials. We aimed to assess the predictive performance of Delta(SOFA) for 28-day mortality. Methods Data from two previously published randomized controlled trials were studied: the first reporting on patients with severe Gram-negative infections as a derivation cohort and the second reporting on patients with ventilator-associated pneumonia as a validation cohort. Only patients with sepsis according to the Sepsis-3 definition were included in this analysis. SOFA scores were calculated on days 1, 2, 3, 5, 7, 14, and 28. Results We included 448 patients within the derivation cohort and 199 within the validation cohort. Mean SOFA scores on day 1 were 6.06 +/- 4.07 and 7.84 +/- 3.39, and 28 day mortality 22.8% and 29.6%, respectively. In the derivation cohort, the earliest time point where Delta(SOFA) score predicted mortality was day 7 (AUROC (95% CI) 0.84 (0.80-0.89); p < 0.001). The best tradeoff for prediction was found with 25% changes (78% sensitivity, 80% specificity); less than 25% decrease of admission SOFA was associated with increased mortality (odds ratio for death 14.87). This finding was confirmed in the validation cohort. Conclusions Delta(SOFA) on day 7 is a useful early prognostic marker of 28-day mortality and could serve as an endpoint in future sepsis trials alongside mortality.
引用
收藏
页数:8
相关论文
共 20 条
  • [1] [Anonymous], GUID IND AC BACT SKI
  • [2] [Anonymous], GUID IND COMM ACQ BA
  • [3] DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS
    BONE, RC
    BALK, RA
    CERRA, FB
    DELLINGER, RP
    FEIN, AM
    KNAUS, WA
    SCHEIN, RMH
    SIBBALD, WJ
    [J]. CHEST, 1992, 101 (06) : 1644 - 1655
  • [4] Effect of Empirical Treatment With Moxifloxacin and Meropenem vs Meropenem on Sepsis-Related Organ Dysfunction in Patients With Severe Sepsis A Randomized Trial
    Brunkhorst, Frank M.
    Oppert, Michael
    Marx, Gernot
    Bloos, Frank
    Ludewig, Katrin
    Putensen, Christian
    Nierhaus, Axel
    Jaschinski, Ulrich
    Meier-Hellmann, Andreas
    Weyland, Andreas
    Gruendling, Matthias
    Moerer, Onnen
    Riessen, Reimer
    Seibel, Armin
    Ragaller, Maximilian
    Buechler, Markus W.
    John, Stefan
    Bach, Friedhelm
    Spies, Claudia
    Reill, Lorenz
    Fritz, Harald
    Kiehntopf, Michael
    Kuhnt, Evelyn
    Bogatsch, Holger
    Engel, Christoph
    Loeffler, Markus
    Kollef, Marin H.
    Reinhart, Konrad
    Welte, Tobias
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (22): : 2390 - 2399
  • [5] Prognostic evaluation of severe sepsis and septic shock: Procalcitonin clearance vs Δ Sequential Organ Failure Assessment
    de Azevedo, Jose R. A.
    Torres, Orlando J. M.
    Beraldi, Rafael A.
    Ribas, Carmen A. P. M.
    Malafaia, Osvaldo
    [J]. JOURNAL OF CRITICAL CARE, 2015, 30 (01) : 219.e9 - 219.e12
  • [6] SOFA and mortality endpoints in randomized controlled trials: a systematic review and meta-regression analysis
    de Grooth, Harm-Jan
    Geenen, Irma L.
    Girbes, Armand R.
    Vincent, Jean-Louis
    Parienti, Jean-Jacques
    Straaten, Heleen M. Oudemans-van
    [J]. CRITICAL CARE, 2017, 21
  • [7] Serial evaluation of the SOFA score to predict outcome in critically ill patients
    Ferreira, FL
    Bota, DP
    Bross, A
    Mélot, C
    Vincent, JL
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (14): : 1754 - 1758
  • [8] Giamarellos-Bourboulis EJ, 2014, J ANTIMICROB CHEMOTH, V69, P1118, DOI [10.1093/jac/dkt475, DOI 10.1093/JAC/DKT475]
  • [9] Effect of clarithromycin in patients with sepsis and ventilator-associated pneumonia
    Giamarellos-Bourboulis, Evangelos J.
    Pechere, Jean-Claude
    Routsi, Christina
    Plachouras, Diamantis
    Kollias, Spyridon
    Raftogiannis, Maria
    Zervakis, Dimitrios
    Baziaka, Fotini
    Koronaios, Apostolos
    Antonopoulou, Anastasia
    Markaki, Vassiliki
    Koutoukas, Pantelis
    Papadomichelakis, Evangelos
    Tsaganos, Thomas
    Armaganidis, Apostolos
    Koussoulas, Vassilios
    Kotanidou, Anastasia
    Roussos, Charis
    Giamarellou, Helen
    [J]. CLINICAL INFECTIOUS DISEASES, 2008, 46 (08) : 1157 - 1164
  • [10] Levosimendan for the Prevention of Acute Organ Dysfunction in Sepsis
    Gordon, A. C.
    Perkins, G. D.
    Singer, M.
    McAuley, D. F.
    Orme, R. M. L.
    Santhakumaran, S.
    Mason, A. J.
    Cross, M.
    Al-Beidh, F.
    Best-Lane, J.
    Brealey, D.
    Nutt, C. L.
    McNamee, J. J.
    Reschreiter, H.
    Breen, A.
    Liu, K. D.
    Ashby, D.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (17) : 1638 - 1648